Kezar Life Sciences (KZR)
(Delayed Data from NSDQ)
$3.76 USD
0.00 (0.00%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Kezar Life Sciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
KZR 3.76 0.00(0.00%)
Will KZR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KZR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KZR
All You Need to Know About Kezar Life Sciences (KZR) Rating Upgrade to Buy
Kezar Life Sciences (KZR) Upgraded to Buy: What Does It Mean for the Stock?
KZR: What are Zacks experts saying now?
Zacks Private Portfolio Services
VistaGen Therapeutics, Inc. (VTGN) Reports Q2 Loss, Misses Revenue Estimates
Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates
What Makes Kezar Life Sciences (KZR) a New Buy Stock
Other News for KZR
Platina Resources Divests Xanadu Project to Focus on Mt McKenna Gold Exploration
Kalamazoo Resources Announces Proposed Securities Issue
Kalamazoo Resources Expands Ashburton Gold Project with Strategic Acquisition
KZR forms Lower Bollinger Band Walk on September 19
Is KZR setting up for a drop? Lower Bollinger Band Walk shows up after advancing 0.53%